157,811 Shares in Cameco Corporation $CCJ Bought by ARP Global Capital Ltd

Key Points

• ARP Global Capital Ltd bought 157,811 shares of Cameco (NYSE:CCJ) in Q4, a stake worth about $14.44 million that represents 4.4% of the firm's holdings and is its seventh-largest position.
• Cameco beat Q4 estimates with $0.36 EPS vs. $0.29 and $874.6M revenue, and Wall Street remains largely positive (13 Buys, 2 Holds) with a consensus price target of $150.40.

ARP Global Capital Ltd purchased a new stake in shares of Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 157,811 shares of the basic materials company's stock, valued at approximately $14,438,000. Cameco accounts for 4.4% of ARP Global Capital Ltd's holdings, making the stock its 7th biggest position.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Financial Consulate Inc. acquired a new position in shares of Cameco in the third quarter worth about $25,000. Nisa Investment Advisors LLC acquired a new stake in shares of Cameco during the 4th quarter valued at about $25,000. Founders Capital Management acquired a new stake in shares of Cameco during the 4th quarter valued at about $27,000. Strategic Advocates LLC purchased a new position in shares of Cameco in the 3rd quarter valued at about $28,000. Finally, Mcguire Capital Advisors Inc. acquired a new position in Cameco in the 4th quarter worth about $28,000. Hedge funds and other institutional investors own 70.21% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on CCJ shares. Raymond James Financial reiterated an "outperform" rating on shares of Cameco in a research report on Wednesday, January 14th. Glj Research reaffirmed a "buy" rating and set a $171.20 target price (up from $100.00) on shares of Cameco in a research note on Wednesday, February 18th. Zacks Research lowered Cameco from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 18th. The Goldman Sachs Group reissued a "buy" rating and issued a $131.00 price target on shares of Cameco in a research note on Wednesday, February 4th. Finally, Royal Bank Of Canada boosted their price target on shares of Cameco from $150.00 to $160.00 and gave the stock an "outperform" rating in a report on Tuesday, February 17th. Thirteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, Cameco has an average rating of "Moderate Buy" and a consensus price target of $150.40.

Cameco Trading Down 0.1%

CCJ stock opened at $115.25 on Friday. Cameco Corporation has a 12-month low of $35.00 and a 12-month high of $135.24. The business's 50-day moving average is $116.36 and its 200 day moving average is $97.40. The company has a current ratio of 2.47, a quick ratio of 1.68 and a debt-to-equity ratio of 0.14. The stock has a market cap of $50.20 billion, a price-to-earnings ratio of 118.82 and a beta of 0.98.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its earnings results on Friday, February 13th. The basic materials company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.07. The business had revenue of $874.57 million during the quarter, compared to analysts' expectations of $782.13 million. Cameco had a return on equity of 9.35% and a net margin of 17.00%.The business's revenue was up 1.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.36 earnings per share. On average, sell-side analysts anticipate that Cameco Corporation will post 1.27 EPS for the current fiscal year.

About Cameco

Cameco Corporation NYSE: CCJ is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company's operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.